ITMCTR2100004654尚未招募未知
Clinical study on the effectiveness and mechanism of acupuncture combined with donepezil for mild Alzheimer's disease
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 50 至 80（—）
- 性别
- All
入选标准
- •This study is designed to include participants aged 50-80 years with diagnosis of mild AD according to NIA-AA criteria or with a CDR score between 0.5 and 1. The subject included are required to have no history of taking anti-dementia drugs systematically (donepezil excluded), and at least one reliable caretaker who can accompany the subject during treatment is also needed.
排除标准
- •Individuals will be excluded if they have dementia caused by other diseases other than AD, such as cer-ebrovascular diseases, Creutzfeldt-Jakob disease and Parkinsons disease; a history of psychological disorders (DSM-IV criteria); uncorrectable visual or auditory impairment that hampers the completion of related examination. Patients could not participate this study if they are allergic to acupuncture or pace-maker installed. Pre-menopausal women will also be excluded.
研究者
相似试验
尚未招募
1 期
Investigating the clinical efficacy and mechanism of Runfei Huayu recipe in treating connective tissue disease merger interstitial lung disease based on Th17/Treg glycolytic pathwayITMCTR2200006523Taizhou Hospital of traditional Chinese Medicine
尚未招募
1 期
Clinical Efficacy Evaluation and Mechanism Study of Anti-Hepatic Fibrosis Effectively Treated Prescription by Supplementing Deficiency and Clearing CollateralsITMCTR2100005161Chengdu University of Traditional Chinese Medicine
进行中（未招募）
不适用
A study to investigate belimumab for the treatment of chronic immune thrombocytopeniaChronic Immune ThrombocytopeniaMedDRA version: 15.1Level: LLTClassification code 10051057Term: Idiopathic thrombocytopeniaSystem Organ Class: 100000004851EUCTR2011-000241-21-DEGlaxoSmithKline Research & Development Limited40
进行中（未招募）
不适用
A study to investigate belimumab for the treatment of chronic immune thrombocytopeniaChronic Immune ThrombocytopeniaMedDRA version: 14.1Level: LLTClassification code 10051057Term: Idiopathic thrombocytopeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-000241-21-GBGlaxoSmithKline Research & Development Limited40
尚未招募
1 期
The research of the clinical effect and mechanism of Zhishen Tiaoxing Tuina therapy on Chronic Fatigue Immune Dysfunction SyndromeChronic Fatigue SyndromeITMCTR2024000081Affiliated Hospital of Changchun University of Traditional Chinese Medicine